Trial Profile
Efficacy and tolerability of solifenacin and tolterodine in Taiwanese patients with overactive bladder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2011
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 07 Mar 2011 New trial record